Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024:1460:97-129.
doi: 10.1007/978-3-031-63657-8_4.

Lipid Storage, Lipolysis, and Lipotoxicity in Obesity

Affiliations
Review

Lipid Storage, Lipolysis, and Lipotoxicity in Obesity

Atilla Engin. Adv Exp Med Biol. 2024.

Abstract

The ratio of free fatty acid (FFA) turnover decreases significantly with the expansion of white adipose tissue. Adipose tissue and dietary saturated fatty acid levels significantly correlate with an increase in fat cell size and number. The G0/G1 switch gene 2 increases lipid content in adipocytes and promotes adipocyte hypertrophy through the restriction of triglyceride (triacylglycerol: TAG) turnover. Hypoxia in obese adipose tissue due to hypertrophic adipocytes results in excess deposition of extracellular matrix (ECM) components. Cluster of differentiation (CD) 44, as the main receptor of the extracellular matrix component regulates cell-cell and cell-matrix interactions including diet-induced insulin resistance. Excess TAGs, sterols, and sterol esters are surrounded by the phospholipid monolayer surface and form lipid droplets (LDs). Once LDs are formed, they grow up because of the excessive amount of intracellular FFA stored and reach a final size. The ratio of FFA turnover/lipolysis decreases significantly with increases in the degree of obesity. Dysfunctional adipose tissue is unable to expand further to store excess dietary lipids, increased fluxes of plasma FFAs lead to ectopic fatty acid deposition and lipotoxicity. Reduced neo-adipogenesis and dysfunctional lipid-overloaded adipocytes are hallmarks of hypertrophic obesity linked to insulin resistance. Obesity-associated adipocyte death exhibits feature of necrosis-like programmed cell death. Adipocyte death is a prerequisite for the transition from hypertrophic to hyperplastic obesity. Increased adipocyte number in obesity has life-long effects on white adipose tissue mass. The positive correlation between the adipose tissue volume and magnetic resonance imaging proton density fat fraction estimation is used for characterization of the obesity phenotype, as well as the risk stratification and selection of appropriate treatment strategies. In obese patients with type 2 diabetes, visceral adipocytes exposed to chronic/intermittent hyperglycemia develop a new microRNAs' (miRNAs') expression pattern. Visceral preadipocytes memorize the effect of hyperglycemia via changes in miRNAs' expression profile and contribute to the progression of diabetic phenotype. Nonsteroidal anti-inflammatory drugs, metformin, and statins can be beneficial in treating the local or systemic consequences of white adipose tissue inflammation. Rapamycin inhibits leptin-induced LD formation. Collectively, in this chapter, the concept of adipose tissue remodeling in response to adipocyte death or adipogenesis, and the complexity of LD interactions with the other cellular organelles are reviewed. Furthermore, clinical perspective of fat cell turnover in obesity is also debated.

Keywords: Adipocyte; Adipose triglyceride lipase (ATGL); Fat cell; Free fatty acids; Hormone-sensitive lipase (HSL); Lipid droplets; Lipotoxicity; Obesity; Perilipin (PLIN); Peroxisome proliferator-activated receptor-gamma (PPARγ); Sterol regulatory element-binding protein (SREBP); Triacylglycerol (TAG).

PubMed Disclaimer

References

    1. Abais JM, Xia M, Zhang Y, Boini KM, Li P-L (2015) Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid Redox Signal 22:1111–1129. https://doi.org/10.1089/ars.2014.5994 - DOI - PMC
    1. Abdelaziz R, Elbasel M, Esmat S, Essam K, Abdelaaty S (2015) Tissue inhibitors of Metalloproteinase-1 and 2 and obesity related non-alcoholic fatty liver disease: is there a relationship. Digestion 92:130–137. https://doi.org/10.1159/000439083 - DOI
    1. Abdesselem H, Madani A, Hani A, Al-Noubi M, Goswami N, Ben Hamidane H, Billing AM, Pasquier J, Bonkowski MS, Halabi N, Dalloul R, Sheriff MZ, Mesaeli N, ElRayess M, Sinclair DA, Graumann J, Mazloum NA (2016) SIRT1 limits adipocyte hyperplasia through c-Myc inhibition. J Biol Chem 291:2119–2135. https://doi.org/10.1074/jbc.M115.675645 - DOI
    1. Abdullahi A, Jeschke MG (2017) Taming the flames: targeting white adipose tissue browning in hypermetabolic conditions. Endocr Rev 38:538–549. https://doi.org/10.1210/er.2017-00163 - DOI - PMC
    1. Albert JS, Yerges-Armstrong LM, Horenstein RB, Pollin TI, Sreenivasan UT, Chai S, Blaner WS, Snitker S, O’Connell JR, Gong D-W, Breyer RJ, Ryan AS, McLenithan JC, Shuldiner AR, Sztalryd C, Damcott CM (2014) Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. N Engl J Med 370:2307–2315. https://doi.org/10.1056/NEJMoa1315496 - DOI - PMC

LinkOut - more resources